Silence Therapeutics PLC-ADRSLN
13F holders, Q1 2024 (March 31)64holders
5famous investors
$21.21avg. 13F price*
At the end of Q1 2024, 64 institutions reported holding Silence Therapeutics PLC-ADR (SLN) in their 13F filings. The largest holders were TCG Crossover Management, LLC ($71.2M), Artal Group S.A. ($60.0M) and Lombard Odier Asset Management (Europe) Ltd ($48.3M). 5 famous investors held it, including Stanley Druckenmiller (0.2% of Duquesne Family Office's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Silence Therapeutics PLC-ADR
- CUSIP
- 82686Q101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 32 | $186.8M |
| Exits | 2 | $26.2M |
Ownership 64 holders
| TCG Crossover Management, LLC | 5.63% | Add +56.6% | 3,295,350 | $71.2M |
| Artal Group S.A. | 1.55% | Reduce -7.3% | 2,779,619 | $60.0M |
| Lombard Odier Asset Management (Europe) Ltd | 4.76% | Reduce -38.0% | 2,238,039 | $48.3M |
| Redmile Group, LLC | 1.61% | New | 2,027,669 | $43.8M |
| Lombard Odier Asset Management (USA) Corp | 6.14% | Reduce -38.4% | 2,388,912 | $41.6M |
| Deep Track Capital, LP | 1.02% | Reduce -15.8% | 1,643,881 | $35.5M |
| Logos Global Management LP | 3.27% | Add +269.0% | 1,476,061 | $31.1M |
| Frazier Life Sciences Management, L.P. | 1.05% | Add +30.4% | 1,148,591 | $24.8M |
| Vivo Capital, LLC | 1.88% | Add +116.7% | 1,105,454 | $23.9M |
| Nextech Invest Ltd. | 3.26% | New | 952,400 | $20.6M |
| Janus Henderson Group PLC | 0.01% | New | 625,864 | $13.6M |
| Cormorant Asset Management, LP | 0.59% | New | 625,000 | $13.5M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | New | 600,000 | $13.0M |
| Aquilo Capital Management, LLC | 9.30% | Reduce -45.0% | 574,214 | $12.4M |
| Lynx1 Capital Management LP | 2.93% | Add +123.3% | 526,642 | $11.4M |
| Polar Capital Holdings Plc | 0.06% | New | 500,000 | $10.8M |
| 5AM Venture Management, LLC | 2.30% | New | 476,200 | $10.3M |
| Millennium Management | 0.01% | New | 409,418 | $8.8M |
| Duquesne Family Office | 0.22% | New | 387,400 | $8.4M |
| Mangrove Partners Im, LLC | 0.72% | New | 385,408 | $8.3M |
| Octagon Capital Advisors LP | 0.83% | New | 315,000 | $6.8M |
| M28 Capital Management LP | 4.78% | Reduce -17.7% | 299,400 | $6.5M |
| Hudson Bay Capital Management LP | 0.06% | New | 276,590 | $6.0M |
| Parkman Healthcare Partners LLC | 0.65% | Add +5.0% | 244,471 | $5.3M |
| Morgan Stanley | 0.00% | Add +286.5% | 242,770 | $5.2M |
| Woodline Partners LP | 0.05% | Add +383.8% | 238,380 | $5.1M |
| Nantahala Capital Management, LLC | 0.43% | New | 200,000 | $4.3M |
| HSBC Holdings PLC | 0.00% | No change | 177,834 | $3.8M |
| Marshall Wace, LLP | 0.01% | New | 139,191 | $3.0M |
| Schonfeld Strategic Advisors LLC | 0.02% | Add +170.3% | 133,000 | $2.9M |
| Boothbay Fund Management, LLC | 0.09% | New | 127,224 | $2.7M |
| Two Sigma Investments, LP | 0.01% | New | 107,212 | $2.3M |
| Renaissance Technologies | 0.00% | Add +283.4% | 103,900 | $2.2M |
| Cantor Fitzgerald, L. P. | 0.54% | Reduce -29.5% | 103,483 | $2.2M |
| Walleye Capital LLC | 0.02% | New | 91,819 | $2.0M |
| BIT Capital GmbH | 0.17% | New | 89,000 | $1.9M |
| Two Sigma Advisers, LP | 0.00% | New | 77,400 | $1.7M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.05% | Reduce -22.5% | 72,223 | $1.6M |
| UBS Group AG | 0.00% | Add +2.8% | 71,918 | $1.6M |
| Citigroup Inc. | 0.00% | No change | 58,333 | $1.3M |
| Artia Global Partners LP | 0.28% | New | 52,476 | $1.1M |
| Citadel Advisors | 0.00% | Add +96.4% | 42,682 | $922K |
| ADAR1 Capital Management, LLC | 0.24% | Add +21000.0% | 40,090 | $866K |
| Cubist Systematic Strategies, LLC | 0.01% | New | 36,281 | $784K |
| Blair William & Co. | 0.00% | Reduce -0.5% | 25,432 | $549K |
| Geode Capital Management, LLC | 0.00% | No change | 22,427 | $484K |
| Goldman Sachs Group Inc. | 0.00% | New | 21,739 | $470K |
| Trexquant Investment LP | 0.01% | New | 21,047 | $455K |
| Rathbones Group PLC | 0.00% | New | 19,906 | $430K |
| Jump Financial, LLC | 0.01% | New | 18,800 | $406K |
| Shay Capital LLC | 0.10% | New | 15,150 | $327K |
| Bank of America Corp. | 0.00% | Add +1014.5% | 11,992 | $259K |
| NEOS Investment Management LLC | 0.02% | New | 11,656 | $252K |
| Osaic Holdings, Inc. | 0.00% | New | 10,922 | $236K |
| JPMorgan Chase & Co. | 0.00% | New | 9,610 | $208K |
| Point72 Asset Management | 0.00% | New | 8,200 | $177K |
| SG Americas Securities, LLC | 0.00% | Add +10.5% | 7,000 | $151K |
| Barclays PLC | 0.00% | New | 5,570 | $120K |
| Qube Research & Technologies Ltd | 0.00% | Add +2114.6% | 3,942 | $85K |
| Lazard Asset Management LLC | 0.00% | Reduce -37.7% | 1,415 | $29K |
| Advisors Preferred, LLC | 0.00% | New | 1,109 | $24K |
| GAMMA Investing LLC | 0.00% | Reduce -4.6% | 876 | $19K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 100 | $2K |
| Rhumbline Advisers | 0.00% | Add +200.0% | 15 | $324 |
"% of holder's portfolio" is SLN's weight in each manager's 13F, not the share of Silence Therapeutics PLC-ADR the manager owns.